Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation

Cell Growth and Differentiation

Volumn 10, Issue 9, 1999, Pages 639-654

  Lerga, Ana ^a   Crespo, Piero ^a   Berciano, Maite ^a   Delgado, M Dolores ^a   Cañelles, Matilde ^a   Calés, Carmela ^e   Richard, Carlos ^b   Ceballos, Eva ^a   Gutierrez, Pilar ^a   Ajenjo, Nuria ^a   Gutkind, Silvio ^c   Léon, Javier ^a,d  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C;

ARTICLE; CELL DIFFERENTIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; ONCOGENE C MYC; PRIORITY JOURNAL;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOGENS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; K562 CELLS; MACROPHAGES; MONOCYTES; PHENOTYPE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-MYC; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS;

EID: 0032857094     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Marcu, K. B., Bossone, S. A., and Pattel, A. J. MYC function and regulation. Annu Rev. Biochem., 61: 809-860, 1992.
2. Henriksson, M., and Lüscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
3. Amati, B., Alevizopoulos, K., and Vlach, J. Myc and the cell cycle. Front. Biosci., 3: d250-d268, 1998.
4. Bouchard, C., Staller, P., and M. Eilers. Control of cell proliferation by Myc. Trends Cell Biol., 8: 202-206, 1998.
5. Blackwood, E. M., and Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (Washington DC), 251: 1211-1217, 1991.
6. Prendergast, G. C., Lawe, D., and Ziff, E. B. Association of Myn, the murine homologue of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell, 65: 395-407, 1991.
7. Grandori, C., and Eisenman, R. N. Myc target genes. Trends Biochem. Sci., 22: 177-181, 1997.
8. Dang, C. V. c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell. Biol., 19: 1-11, 1999.
9. Einat, M., Resnitzky, D., and Kimchi, A. A close link between reduction of c-myc expression by Interferon and G0/G1 arrest. Nature (Lond.), 313: 597-600, 1985.
10. Grosso, L. E., and Pitot, H. C. Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures. Cancer Res., 45: 847-850, 1985.
11. Long, M. W., Heffner, C. H., Williams, J. L., and Prochownik, E. V. Regulation of megakaryocyte phenotype in human erythroleukemia. J. Clin. Invest., 85: 1072-1084, 1990.
12. Derigs, H. G., Morgan, D. A., Hoffman, R., Litz, S. L., Srour, E. F., Brandt, J. E., and Boswell, H. S. AP-1/c-jun and c-myc regulation during megakaryocytic differentiation of a human bipotential growth factor-dependent cell line. Platelets, 6: 24-30, 1995.
13. Ayer, D. E., and Eisenman, R. N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev., 7: 2110-21119, 1993.
14. Larsson, L-G., Pettersson, M., Öberg, F., Nilsson, K., and Lüscher, B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene, 9: 1247-1252, 1994.
15. Delgado, M. D., Lerga, A., Cañelles, M., Gómez-Casares, M. T., and León, J. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene, 10: 1659-1665, 1995.
16. Nishikawa, M., and Shirakawa, S. The expression and possible roles of protein kinase C in haemopoietic cells. Leuk. Lymphoma, 8: 201-211, 1992.
17. Aihara, H., Asaoka, Y., Yoshida, K., and Nishizuka, Y. Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc. Natl. Acad. Sci. USA, 88: 11062-11067, 1991.
18. Tonetti, D. A., Henning-Chubb, C., Yamanishi, D., and Huberman, E. Protein kinase C-β is required for macrophage differentiation of human HL-60 leukemia cells. J. Biol. Chem., 269: 23230-23235, 1994.
19. Rossi, F., McNagny, K. M., Smith, G., Frampton, J., and Graf, T. Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity. EMBO J., 15: 1894-1901, 1996.
20. Ebeling, J. G., Vandenbark, G. R., Kuhn, L. J., Ganong, B. R., Bell, R. M., and Niedel, J. E. Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc. Natl. Acad. Sci. USA, 82: 815-819, 1985.
21. Murray, N. R., Baumgardner G. P., Bums D. J., and Fields, A. P. Protein kinase C isotypes in human erythroloukemia (K562) cell proliferation and differentiation. J. Biol. Chem., 268: 15847-15853, 1993.
22. Hong, Y., Martin, J. F., Vainchenker, W., and Erusallimsky, J. D. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Blood, 87: 123-131, 1996.
23. Gailani, D., Cadwell, F. J., O'Donnell, P. S., Hromas, R. A., and Macfarlane, D. E. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes. Cancer Res., 49: 5329-5333, 1989.
24. Simpson, R. U., Hsu, T., Wendt, M. D., and Taylor, J. M. 1,25-Dihydroxyvitamin D3 regulation of c-myc protooncogene transcription. Possible involvement of protein kinase C, J. Biol. Chem., 264: 19710-19715, 1989.
25. Berstein, S. H., Kharbanda, S. M., Sherman, M. L., Stone, R. M., and Kufe, D. W. Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells. FEBS Lett., 294: 73-76, 1991.
26. Holt, J. T., Redner, R. L., and Nienhuis, A. W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell. Biol., 8: 963-973, 1988.
27. Bacon, T. A, and Wickstrom, E. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media. Oncogene Res., 6: 21-32, 1991.
28. Yokoyama, K., and Imamoto, F. Transcriptional control of the endogenous MYC protooncogene by antisense RNA. Proc. Natl. Acad. Sci. USA, 84: 7363-7367, 1987.
29. Rowley, P. T., Ohlsson-Wilhelm, B. M., Farley, B. A., and LaBella, S. Inducers of erythroid differentiation in K562 human leukemia cells. Exp. Hematology, 9: 32-37, 1981.
30. DeLuca, L. C., Mitchell, T., Spriggs, D., and Kufe, D. W. Induction of terminal differentiation in human K-562 erythroleukemia cells by arabino-furanosyl cytosine. J. Clin. Investig., 74: 821-827, 1984.
31. Sutherland, J. A., Turner, A. R., Mannoni, P., McGann, L. E., and Turc, J. M. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Response Modif., 5: 250-262, 1986.
32. Leary, J. F., Ohlsson-Wilhelm, B. M., Giuliano, R., LaBella, S., Farley, B., and Rowley, P. T. Mutipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk. Res., 11: 807-815, 1987.
33. Alitalo, R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk. Res., 14: 501-514, 1990.
34. Delgado, M. D., Quincoces, A. F., Gómez-Casares, M. T., Cuadrado, M. A., Richard, C., and León, J. Differential expression of ras protooncogenes during induced differentiation of human erythroleukemia cells. Cancer Res., 52: 5979-5984, 1992.
35. Cañelles, M., Delgado, M. D., Hyland, K. M., Lerga, A., Richard, C., Dang, C. V., and León, J. Max and inhibitory c-Myc mutants induce erythroid differentiation and resistant to apoptosis in human leukemia cells. Oncogene, 14: 1315-1327, 1997.
36. Tani, T., Ylänne, J., and Virtanen, I. Expression of megakaryocytic and erythroid properties in human leukemic cells. Exp. Hematol., 24: 158-168, 1996.
37. Vanags, D. M., Orrenius, S., and Aguilar-Santelises, M. Alterations in the Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process. Br. J. Haematol., 99: 824-831, 1997.
38. Zauli, G., Vitale, M., Falcieri, E., Gibellini, D., Bassini, A., Celeghini, C., Columbaro, M., and Capitani, S. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood, 90: 2234-2243, 1997.
39. Isenberg, W. M., and Bainton, D. F. Megakaryocyte and platelet structure. In: R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, H. J. Cohen, and L. E. Silberstein (eds.), Hematology. Basic Principles and Practice, Ed. 2, pp. 1516-1524. NY: Churchill Livinstone, 1995.
40. Gómez-Casares, M. T., Delgado, M. D., Lerga, A., Crespo, P., Quincoces, A. F., Richard, C., and León, J. Down-regulation of C-MYC gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells. Leukemia (Baltimore), 7: 1824-1833, 1993.
41. Goodnight, J., Mishak, H., and Mushinski, J. F. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv. Cancer Res., 64: 159-209, 1994.
42. Walker, D. H. Small-molecule inhibitors of cyclin-dependent kinases: molecular tools and potential therapeutics. Curr. Top. Microbiol. Immunol., 227: 149-165, 1998.
43. Hocevar, B. A., Morrow, D. M., Tykocinski, M. L., and Fields, A. P. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J. Cell Sci., 101: 671-679, 1992.
44. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., and Kirilowsky, J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266: 15771-15781, 1991.
45. Alitalo, R., Partanen, J., Pertovaara, L., Holtta, E., Sistonen, L., Andersson, L., and Alitalo, K. Increased erythroid potentiating activity/ tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells. Blood, 75: 1974-1982, 1990.
46. Grignani, F., Lombardi, L., Inghirami, G., Sterna, S. L., Cechova, K., and Dalla-Favera, R. Negative autoregulation of c-myc gene expression is activated in transformed cells. EMBO J., 9: 3913-3922, 1990.
47. Facchini, L. M., Chen, S., Marhin, W. W., Lear, J. N., and Penn, L. Z. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol., 17: 100-114, 1997.
48. Yen, A., Varvayanis, S., and Platko, J. D. 12-O-Tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemia cells. Cancer Res., 53: 3085-3091, 1993.
49. Hurlin, P. J., Foley, K. P., Ayer, D. E., Eisenman, R. N., Hanahan, D., and Arbeit, J. M. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene, 11: 2487-2501, 1995.
50. Larsson, L. G., Bahram, F., Burkhardt, H., and Luscher, B. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Oncogene, 15: 737-748, 1997.
51. 2+-sensitive phospholipid-dependent protein kinase activity in phorbol estertreated 3T3 cells. Biochem. Biophys. Res. Commun., 120: 1053-1059, 1984.
52. Coppola, J. A., and Cole, M. D. Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature (Lond.), 320: 760-763, 1986.
53. Dmitrovski, E., Kuehk, W. M., Hollins, G. F., Kirsch, I. R., Bender, T. P., and Segal, S. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature (Lond.), 322: 748-750, 1986.
54. 1 progression in murine erythroleukemia cells. Mol. Cell. Biol., 8: 3683-3695, 1988.
55. Chisholm, O., Stapleton, P., and Symonds, G. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction. Oncogene, 7: 1827-1836, 1992.
56. Hoffman-Liebermann, B., and Liebermann, D. A. Interteukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol. Cell. Biol., 11: 2375-2381, 1991.
57. Dotto, G. P., Gilman, M. Z., Maruyama, M., and Weinberg, R. A. c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBO J., 11: 2863-2857, 1886.
58. Gandarillas, A., and Watt, F. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev., 11: 2869-2882, 1997.
59. Schneider, M. D., Perryman, M. B., Payne, P. A., Spizz, G., Roberts, R., and Olson, E. N. Autonomous expression of c-myc in BC3H1 cells partially inhibited but does not prevent myogenic differentiation. Mol. Cell. Biol., 7: 1973-1977, 1987.
60. Crescenzi, M., Crouch, D. H., and Tato, F. Transformation by myc prevents fusion but not biochemical differentiation of C212 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J. Cell. Biol., 125: 1137-1145, 1994.
61. Barnett, S. C., and Crouch, D. H. The effect of oncogenes on the growth and differentiation of oligodendrocyte type 2 astrocyte progenitor cells. Cell Growth Differ., 6: 69-80, 1995.
62. Alema, S., Tato, F., and Boettiger, D. myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts. Mol. Cell. Biol., 5: 538-544, 1985.
63. Nishikura, K., Kim, U., and Murray, J. M. Differentiation of F9 cells is independent of c-myc expression. Oncogene, 5: 981-988, 1990.
64. Larsson, L-G., Ivhed, I., Gidlund, M., Pettersson, U., and Vennström, B. Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. Proc. Natl. Acad. Sci. USA, 85: 2638-2642, 1988.
65. Miller, D., Miller, D. J., Garcia, J. V., and Lynch, C. M. Use of retroviral vectors for gene transfer and expression. Methods Enzymol., 217: 581-599, 1993.
66. Yam, L., Li, C., and Crosby, W. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol., 55: 283-291, 1971.
67. Chomczynski, P., and Sacchi, N. Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
68. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
69. Yasuda, I., Kishimoto, A., Tanaka, S., Tominaga, M., Sakurai, A., and Nishizuka, Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochim. Biophys. Res. Commun., 166: 1220-1227, 1990.
70. House, C., and Kemp, B. E. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science (Washington DC), 238: 1726-1728, 1987.